Gene: C3orf18
Official Full Name: chromosome 3 open reading frame 18provided by HGNC
Gene Summary: Predicted to be located in membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO22915 | C3orf18 Knockout cell line (HeLa) | Human | C3orf18 | 1:3~1:6 | Negative | Online Inquiry |
KO22916 | C3orf18 Knockout cell line (HCT 116) | Human | C3orf18 | 1:2~1:4 | Negative | Online Inquiry |
KO22917 | C3orf18 Knockout cell line (A549) | Human | C3orf18 | 1:3~1:4 | Negative | Online Inquiry |
C3orf18 Gene Knockout Cell Lines are genetically engineered cell models specifically designed to study the function and role of the C3orf18 gene, a gene implicated in various biological processes, including cell signaling, immune responses, and metabolic pathways. These knockout cell lines utilize CRISPR/Cas9 technology to selectively disrupt the C3orf18 gene, resulting in a loss-of-function phenotype that allows researchers to investigate the gene’s contributions to cellular behavior and pathology.
The primary function of these knockout cell lines lies in their ability to unveil the molecular mechanisms associated with C3orf18. By comparing the physiological and biochemical characteristics of knockout cells with their wild-type counterparts, researchers can pinpoint how the absence of C3orf18 impacts cellular processes such as proliferation, differentiation, and apoptosis. This detailed mechanistic understanding is crucial for both basic research and the development of targeted therapies, particularly in the context of diseases like cancer or metabolic disorders where gene function is disrupted.
From a scientific standpoint, these cell lines serve as invaluable tools in both research and clinical applications. They can facilitate the discovery of novel therapeutic targets and biomarkers, and help elucidate the underlying causes of diseases associated with C3orf18 dysregulation. In drug development, they allow for high-throughput screening of potential compounds that could restore normal function or counteract deleterious effects.
What sets C3orf18 Gene Knockout Cell Lines apart from alternative models is their precision and reliability in mimicking the loss of the C3orf18 gene’s function. Unlike conventional knockdown methods, which may only reduce gene expression, these knockout lines result in complete gene disruption, providing a clearer understanding of the gene's role. Additionally, they are readily available in various cell types, offering flexibility to researchers studying different biological contexts.
For researchers and clinicians alike, the value of C3orf18 Gene Knockout Cell Lines lies in their capability to deepen our understanding of genetics and contribute to therapeutic advances. Their development represents our commitment to providing high-quality, cutting-edge genetic tools that align with the evolving needs of the scientific community. Our company specializes in delivering innovative biological products that support groundbreaking research and clinical applications, ensuring our customers have access to the best resources available for their studies.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.